Enzo Biochem, Inc. (ENZ)

USD 0.71

(0.73%)

Revenue Summary of Enzo Biochem, Inc.

  • Enzo Biochem, Inc.'s latest annual revenue in 2024 was 31.9 Million USD , up 2.72% from previous year.
  • Enzo Biochem, Inc.'s latest quarterly revenue in 2024 Q3 was 8.02 Million USD , down -6.21% from previous quarter.
  • Enzo Biochem, Inc. reported a annual revenue of 31.06 Million USD in annual revenue 2023, down -70.99% from previous year.
  • Enzo Biochem, Inc. reported a annual revenue of 107.07 Million USD in annual revenue 2022, down -9.05% from previous year.
  • Enzo Biochem, Inc. reported a quarterly revenue of 7.52 Million USD for 2024 Q4, down -6.18% from previous quarter.
  • Enzo Biochem, Inc. reported a quarterly revenue of 7.8 Million USD for 2024 Q1, up 139.7% from previous quarter.

Annual Revenue Chart of Enzo Biochem, Inc. (2024 - 1989)

Historical Annual Revenue of Enzo Biochem, Inc. (2024 - 1989)

Year Revenue Revenue Growth
2024 31.9 Million USD 2.72%
2023 31.06 Million USD -70.99%
2022 107.07 Million USD -9.05%
2021 117.73 Million USD 54.87%
2020 76.02 Million USD -6.34%
2019 81.17 Million USD -22.48%
2018 104.71 Million USD -2.87%
2017 107.8 Million USD 4.9%
2016 102.77 Million USD 5.3%
2015 97.59 Million USD 1.72%
2014 95.94 Million USD 2.39%
2013 93.7 Million USD -9.1%
2012 103.08 Million USD 1.03%
2011 102.02 Million USD 5.1%
2010 97.08 Million USD 8.38%
2009 89.57 Million USD 15.14%
2008 77.79 Million USD 47.04%
2007 52.9 Million USD 32.85%
2006 39.82 Million USD -8.24%
2005 43.4 Million USD 4.22%
2004 41.64 Million USD -21.08%
2003 52.76 Million USD -2.31%
2002 54.01 Million USD -7.52%
2001 58.4 Million USD 16.75%
2000 50.02 Million USD 12.93%
1999 44.3 Million USD 9.65%
1998 40.4 Million USD 15.76%
1997 34.9 Million USD 1.16%
1996 34.5 Million USD 8.83%
1995 31.7 Million USD 39.04%
1994 22.8 Million USD 14.0%
1993 20 Million USD -2.44%
1992 20.5 Million USD 3.54%
1991 19.8 Million USD 2.06%
1990 19.4 Million USD 60.33%
1989 12.1 Million USD 32.97%

Peer Revenue Comparison of Enzo Biochem, Inc.

Name Revenue Revenue Difference
Agilent Technologies, Inc. 6.83 Billion USD 99.533%
Charles River Laboratories International, Inc. 4.12 Billion USD 99.227%
Quest Diagnostics Incorporated 9.25 Billion USD 99.655%
Danaher Corporation 23.89 Billion USD 99.866%
IQVIA Holdings Inc. 14.98 Billion USD 99.787%
Laboratory Corporation of America Holdings 12.16 Billion USD 99.738%
Mettler-Toledo International Inc. 3.78 Billion USD 99.158%
Qiagen N.V. 1.96 Billion USD 98.376%
Revvity, Inc. 2.75 Billion USD 98.84%
Thermo Fisher Scientific Inc. 42.85 Billion USD 99.926%
Waters Corporation 2.95 Billion USD 98.921%